{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:48Z","timestamp":1761058788004},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,4,14]],"date-time":"2008-04-14T00:00:00Z","timestamp":1208131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Mol Allergy"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1476-7961-6-2","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T06:14:24Z","timestamp":1208240064000},"source":"Crossref","is-referenced-by-count":26,"title":["New treatments addressing the pathophysiology of hereditary angioedema"],"prefix":"10.1186","volume":"6","author":[{"suffix":"III","given":"Alvin E","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,14]]},"reference":[{"key":"48_CR1","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","volume":"114","author":"A Agostoni","year":"2004","unstructured":"Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE III, et al.: Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004, 114: S51-131. 10.1016\/j.jaci.2004.06.047","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.iac.2006.08.003","volume":"26","author":"AE Davis III","year":"2006","unstructured":"Davis AE III: Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North America. 2006, 26: 633-651. 10.1016\/j.iac.2006.08.003.","journal-title":"Immunol Allergy Clin North America"},{"key":"48_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/jcp.55.4.266","volume":"55","author":"A Fay","year":"2002","unstructured":"Fay A, Abinun M: Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency). J Clin Pathol. 2002, 55: 266-270.","journal-title":"J Clin Pathol"},{"key":"48_CR4","unstructured":"C1 inhibitor gene mutation database. http:\/\/hae.enzim.hu\/"},{"key":"48_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archinte.161.5.714","volume":"161","author":"K Bork","year":"2001","unstructured":"Bork K, Barnstedt S-E: Treatment of 193 episodes of laryngeal edema with C1-inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001, 161: 714-718. 10.1001\/archinte.161.5.714","journal-title":"Arch Intern Med"},{"key":"48_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1081-1206(10)61121-0","volume":"94","author":"O Roche","year":"2005","unstructured":"Roche O, Blanch A, Caballero T, Sastre N, Callejo D, Lopez TM: Hereditary angioedema due to C1-inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. 2005, 94: 498-503.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"48_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1023\/A:1026416017763","volume":"20","author":"A Stray-Pedersen","year":"2000","unstructured":"Stray-Pedersen A, Abrahamsen TG, Froland SS: Primary immunodeficiency diseases. J Clin Immunol. 2000, 20: 477-485. 10.1023\/A:1026416017763","journal-title":"J Clin Immunol"},{"issue":"4","key":"48_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.iac.2006.09.005","volume":"26","author":"MM Frank","year":"2006","unstructured":"Frank MM: Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North America. 2006, 26 (4): 653-668. 10.1016\/j.iac.2006.09.005","journal-title":"Immunol Allergy Clin North America"},{"key":"48_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1172\/JCI110831","volume":"71","author":"M Quastel","year":"1983","unstructured":"Quastel M, Harrison R, Cicardi M, Alper C, Rosen F: Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest. 1983, 71: 1041-1046. 10.1172\/JCI110831","journal-title":"J Clin Invest"},{"key":"48_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","volume":"119","author":"K Bork","year":"2006","unstructured":"Bork K, Meng G, Staubach P, Hardt J: Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006, 119: 267-274. 10.1016\/j.amjmed.2005.09.064","journal-title":"Am J Med"},{"key":"48_CR11","first-page":"127","volume":"25","author":"S-W Huang","year":"2004","unstructured":"Huang S-W: Results of an on-line survey of patients with hereditary angioedema. Allergy Asthma Proc. 2004, 25: 127-131.","journal-title":"Allergy Asthma Proc"},{"key":"48_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","volume":"101","author":"K Bork","year":"2006","unstructured":"Bork K, Staubach P, Eckardt AJ, Hardt J: Symptoms, courses, and complications of abdominal attacks in hereditary angioedema due to C1-inhibitor deficiency. Am J Gastroenterol. 2006, 101: 619-627. 10.1111\/j.1572-0241.2006.00492.x","journal-title":"Am J Gastroenterol"},{"key":"48_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","volume":"71","author":"A Agostoni","year":"1992","unstructured":"Agostoni A, Cicardi M: Hereditary and acquired C1-inhibitor deficiency: Biological and clinical characteristics in 235 patients. Medicine. 1992, 71: 206-215. 10.1097\/00005792-199207000-00003","journal-title":"Medicine"},{"key":"48_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","volume":"163","author":"K Bork","year":"2003","unstructured":"Bork K, Hardt J, Schicketanz KH, Ressel N: Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003, 163: 1229-1235. 10.1001\/archinte.163.10.1229","journal-title":"Arch Intern Med"},{"key":"48_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4065\/75.4.349","volume":"75","author":"K Bork","year":"2000","unstructured":"Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W: Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc. 2000, 75: 349-354.","journal-title":"Mayo Clin Proc"},{"key":"48_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1078\/0171-2985-00151","volume":"205","author":"IGA Bos","year":"2002","unstructured":"Bos IGA, Hack CE, Abrahams JP: Structural and functional aspects of C1-inhibitor. Immunobiol. 2002, 205: 518-533. 10.1078\/0171-2985-00151.","journal-title":"Immunobiol"},{"key":"48_CR17","doi-asserted-by":"publisher","first-page":"8876","DOI":"10.1021\/bi00100a022","volume":"30","author":"PA Patston","year":"1991","unstructured":"Patston PA, Gettins P, Beechem J, Schapira M: Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate. Biochemistry. 1991, 30: 8876-8882. 10.1021\/bi00100a022","journal-title":"Biochemistry"},{"key":"48_CR18","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","volume":"89","author":"M Cugno","year":"1997","unstructured":"Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM, Agostoni A: Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. 1997, 89: 3213-3218.","journal-title":"Blood"},{"key":"48_CR19","first-page":"38","volume":"121","author":"M Cugno","year":"1993","unstructured":"Cugno M, Hack CE, Boer JPd, Eerenberg AJ, Agostoni A, Cicardi M: Generation of plasmin during acute attacks of hereditary angioedema. J Lab Clin Med. 1993, 121: 38-43.","journal-title":"J Lab Clin Med"},{"key":"48_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clim.2004.05.007","volume":"114","author":"AE Davis III","year":"2005","unstructured":"Davis AE III: The pathophysiology of hereditary angioedema. Clin Immunol. 2005, 114: 3-9. 10.1016\/j.clim.2004.05.007","journal-title":"Clin Immunol"},{"key":"48_CR21","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0021-9258(18)89653-3","volume":"260","author":"RA Pixley","year":"1985","unstructured":"Pixley RA, Schapira M, Colman RW: The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem. 1985, 260: 1723-1729.","journal-title":"J Biol Chem"},{"key":"48_CR22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V69.6.1600.1600","volume":"69","author":"NA Booth","year":"1987","unstructured":"Booth NA, Walker E, Maughan R, Bennett B: Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1. Blood. 1987, 69: 1600-1604.","journal-title":"Blood"},{"key":"48_CR23","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI111360","volume":"93","author":"A Agostini de","year":"1984","unstructured":"de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M: Inactivation of factor-XII active fragment in normal plasma: predominant role of C1-inhibitor. J Clin Invest. 1984, 93: 1542-1549. 10.1172\/JCI111360.","journal-title":"J Clin Invest"},{"key":"48_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1172\/JCI110470","volume":"69","author":"M Schapira","year":"1982","unstructured":"Schapira M, Scott CF, Colman RW: Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest. 1982, 69: 462-468. 10.1172\/JCI110470","journal-title":"J Clin Invest"},{"key":"48_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1172\/JCI110743","volume":"71","author":"F Graaf van der","year":"1983","unstructured":"van der Graaf F, Koedam JA, Bouma BN: Inactivation of kallikrein in human plasma. J Clin Invest. 1983, 71: 149-158. 10.1172\/JCI110743","journal-title":"J Clin Invest"},{"key":"48_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1172\/JCI106022","volume":"48","author":"VH Donaldson","year":"1969","unstructured":"Donaldson VH, Ratnoff OD, Silva WDd, Rosen FS: Permeability-increasing activity in hereditary angioneurotic edema plasma. J Clin Invest. 1969, 48: 642-653. 10.1172\/JCI106022","journal-title":"J Clin Invest"},{"issue":"1","key":"48_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0091-6749(83)90052-0","volume":"72","author":"T Fields","year":"1983","unstructured":"Fields T, Ghebrewihet B, Kaplan A: Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of spontaneous formation of bradykinin. Journal of Allergy and Clinical Immunology. 1983, 72 (1): 54-60. 10.1016\/0091-6749(83)90052-0","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"48_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2249.1994.tb06009.x","volume":"95","author":"LR Shoemaker","year":"1994","unstructured":"Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE III: Hereditary angioneurotic edema: Characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol. 1994, 95: 22-28.","journal-title":"Clin Exp Immunol"},{"key":"48_CR29","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1182\/blood.V90.10.3819","volume":"90","author":"RW Colman","year":"1997","unstructured":"Colman RW, Schmaier AH: Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood. 1997, 90: 3819-3843.","journal-title":"Blood"},{"key":"48_CR30","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A: Plasma bradykinin in angio-oedema. Lancet. 1998, 351: 1693-1697. 10.1016\/S0140-6736(97)09137-X","journal-title":"Lancet"},{"key":"48_CR31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","volume":"104","author":"J Nussberger","year":"1999","unstructured":"Nussberger J, Cugno M, Cicardi M, Agostoni A: Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol. 1999, 104: 1321-1322. 10.1016\/S0091-6749(99)70030-8","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR32","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/archinte.161.20.2417","volume":"161","author":"UC Nzeako","year":"2001","unstructured":"Nzeako UC, Frigas E, Tremaine WJ: Hereditary angioedema. Arch Intern Med. 2001, 161: 2417-2429. 10.1001\/archinte.161.20.2417","journal-title":"Arch Intern Med"},{"key":"48_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0091-6749(97)70095-2","volume":"99","author":"M Cicardi","year":"1997","unstructured":"Cicardi M, Castelli R, Zingale LC, Agostoni A: Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol. 1997, 99: 194-196. 10.1016\/S0091-6749(97)70095-2","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR34","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","volume":"295","author":"J Gelfand","year":"1976","unstructured":"Gelfand J, Sherins R, Alling D, Frank M: Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med. 1976, 295: 1444-1484.","journal-title":"N Engl J Med"},{"issue":"3","key":"48_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0091-6749(81)90181-0","volume":"68","author":"AL Sheffer","year":"1981","unstructured":"Sheffer AL, Fearon DT, Austen KF: Clinical and biochemical effects of stanazolol therapy for hereditary angioedema. J All Clin Immunol. 1981, 68 (3): 181-187. 10.1016\/0091-6749(81)90181-0","journal-title":"J All Clin Immunol"},{"key":"48_CR36","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jaci.2004.12.1130","volume":"115","author":"G Szeplaki","year":"2005","unstructured":"Szeplaki G, Varga L, Valentin S, Kleiber M, Karadi I, Romics L, Fust G, Farkas H: Adverse effects of danazol prophylaxis on lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol. 2005, 115: 864-869. 10.1016\/j.jaci.2004.12.1130","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0015-0282(16)53638-3","volume":"54","author":"JJ Zurlo","year":"1990","unstructured":"Zurlo JJ, Frank MM: The long-term safety of danazol in women with hereditary angioedema. Fertil Steril. 1990, 54: 64-72.","journal-title":"Fertil Steril"},{"key":"48_CR38","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0091-6749(91)90120-D","volume":"87","author":"M Cicardi","year":"1991","unstructured":"Cicardi M, Bergamaschini L, Cugno M, Hack CE, Agostoni G, Agostoni A: Long-term therapy of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. J Allergy Clin Immunol. 1991, 87: 768-773. 10.1016\/0091-6749(91)90120-D","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0091-6749(83)90034-9","volume":"72","author":"M Cicardi","year":"1983","unstructured":"Cicardi M, Bergamaschini L, Tucci A, Agostoni A, Agostoni G, Tornaghi G: Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. J Allergy Clin Immunol. 1983, 72: 294-298. 10.1016\/0091-6749(83)90034-9","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR40","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(99)00110-5","volume":"353","author":"K Bork","year":"1999","unstructured":"Bork K, Pitton M, Harten P, Koch P: Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet. 1999, 353: 1066-1067. 10.1016\/S0140-6736(99)00110-5","journal-title":"Lancet"},{"key":"48_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0168-8278(02)00035-1","volume":"36","author":"K Bork","year":"2002","unstructured":"Bork K, Schneiders V: Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J Hepatol. 2002, 36: 707-709. 10.1016\/S0168-8278(02)00035-1","journal-title":"J Hepatol"},{"issue":"4","key":"48_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/qjmed\/hcg050","volume":"96","author":"C Confavreux","year":"2003","unstructured":"Confavreux C, Seve P, Broussolle C, Renaudier P, Ducert C: Danazol-induced hepatocellular carcinoma. Q J Med. 2003, 96 (4): 315-318.","journal-title":"Q J Med"},{"key":"48_CR43","first-page":"1447","volume":"15","author":"BJ Weill","year":"1988","unstructured":"Weill BJ, Menkes CJ, Cormier C, Louvel A, Dougados M, Houssin D: Hepatocellular carcinoma after danazol therapy. J Rheumatol. 1988, 15: 1447-1449.","journal-title":"J Rheumatol"},{"key":"48_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2249.2005.02726.x","volume":"139","author":"MM Gompels","year":"2005","unstructured":"Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, Fay AC, Longhurst HJ, Morrison L, Price A et al.: C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005, 139: 379-394. 10.1111\/j.1365-2249.2005.02726.x","journal-title":"Clin Exp Immunol"},{"key":"48_CR45","doi-asserted-by":"publisher","first-page":"809","DOI":"10.7326\/0003-4819-93-6-809","volume":"93","author":"SW Hosea","year":"1980","unstructured":"Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM: Long-term therapy of hereditary angioedema with danazol. Ann Intern Med. 1980, 93: 809-812.","journal-title":"Ann Intern Med"},{"key":"48_CR46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11882-007-0039-6","volume":"7","author":"RJ Lock","year":"2007","unstructured":"Lock RJ, Gompels MM: C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies?. Curr Allergy Asthma Rep. 2007, 7: 264-269. 10.1007\/s11882-007-0039-6","journal-title":"Curr Allergy Asthma Rep"},{"key":"48_CR47","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jaci.2007.04.028","volume":"120","author":"L Schneider","year":"2007","unstructured":"Schneider L, Lumry W, Vegh A, Williams AH, Schmalbach T: Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trila of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol. 2007, 120: 416-422. 10.1016\/j.jaci.2007.04.028","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"48_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1473-0502(03)00170-8","volume":"29","author":"A Williams","year":"2003","unstructured":"Williams A, Baird LG: DX-88 and HAE: a developmental perspective. Transfus Apheresis Sci. 2003, 29 (3): 255-258. 10.1016\/S1473-0502(03)00170-8","journal-title":"Transfus Apheresis Sci"},{"key":"48_CR49","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jaci.2007.02.012","volume":"119","author":"K Bork","year":"2007","unstructured":"Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W: Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol. 2007, 119: 1497-1503. 10.1016\/j.jaci.2007.02.012","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.transci.2003.08.006","volume":"29","author":"J Serres De","year":"2003","unstructured":"De Serres J, Groner A, Linder J: Safety and efficacy of pasteurized C1-inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus Apheresis Sci. 2003, 29: 247-254. 10.1016\/j.transci.2003.08.006.","journal-title":"Transfus Apheresis Sci"},{"key":"48_CR51","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jaci.2005.05.019","volume":"116","author":"MBA Doorn van","year":"2005","unstructured":"van Doorn MBA, Burggraaf J, van Dam T, Eerenberg A, Levi M, Hack CE, Shoemaker RC, Cohen AF, Nuijens J: A phase 1 study of recombinant human C1-inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol. 2005, 116: 876-883. 10.1016\/j.jaci.2005.05.019","journal-title":"J Allergy Clin Immunol"},{"key":"48_CR52","unstructured":"Cetor Product Information. http:\/\/www.transfusie.net\/sanquin-eng\/sqn_products_plasma.nsf\/caf2e58949659f41c1256c590043b97d\/11343072be4286d2c125702a004a4e50?OpenDocument"},{"key":"48_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biologicals.2006.08.005","volume":"35","author":"FG Terpstra","year":"2007","unstructured":"Terpstra FG, Kleijn M, Koenderman AHL, Over J, Van Englenberg FAC, van't Woot AB: Viral safety of C1-inhibitor NF. Biologicals. 2007, 35: 173-181. 10.1016\/j.biologicals.2006.08.005","journal-title":"Biologicals"},{"key":"48_CR54","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","volume":"334","author":"AT Waytes","year":"1996","unstructured":"Waytes AT, Rosen FS, Frank MM: Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. New Engl J Med. 1996, 334: 1630-1634. 10.1056\/NEJM199606203342503","journal-title":"New Engl J Med"},{"key":"48_CR55","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaci.2006.01.002","volume":"117","author":"M Levi","year":"2006","unstructured":"Levi M, Choi G, Picavet C, Hack CE: Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. 2006, 117: 904-908. 10.1016\/j.jaci.2006.01.002","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical and Molecular Allergy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-7961-6-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1476-7961-6-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-7961-6-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T04:19:33Z","timestamp":1631074773000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalmolecularallergy.biomedcentral.com\/articles\/10.1186\/1476-7961-6-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,14]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["48"],"URL":"https:\/\/doi.org\/10.1186\/1476-7961-6-2","relation":{},"ISSN":["1476-7961"],"issn-type":[{"value":"1476-7961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,14]]},"article-number":"2"}}